Send a text

Happy Canada day everyone! Today’s guest is Jachym Fibir, Co-Founder and CEO of April19 Discovery. Their innovative AI driven approach uses state-of-the-art computational chemistry to design and develop the next generation of psychedelic-inspired compounds to treat neurodegenerative indications and increase longevity. Listen as we discuss stimulating neuroplasticity, the future of psychedelic medicine and creating non psychedelic psychedelics.

Pluggables:

Jachym's company

Spannr article on dementia treatments

Support the show

As always, if you like what you hear, please leave a review on iTunes. If you want more great content as it releases, subscribe where ever you listen to great podcasts and follow on Instagram for cool updates and episode previews.